IRIS
AZZONI, Cinzia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.863
AS - Asia 2.894
EU - Europa 1.989
SA - Sud America 389
AF - Africa 175
Continente sconosciuto - Info sul continente non disponibili 85
OC - Oceania 7
Totale 9.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.696
SG - Singapore 944
CN - Cina 823
VN - Vietnam 473
IT - Italia 429
IE - Irlanda 319
BR - Brasile 280
SE - Svezia 273
FI - Finlandia 243
HK - Hong Kong 202
DE - Germania 159
BD - Bangladesh 149
ZA - Sudafrica 115
UA - Ucraina 110
CA - Canada 96
FR - Francia 96
GB - Regno Unito 83
NL - Olanda 71
TR - Turchia 71
AT - Austria 50
IN - India 50
RU - Federazione Russa 49
AR - Argentina 43
BE - Belgio 25
IQ - Iraq 23
MX - Messico 20
PL - Polonia 20
PH - Filippine 19
EC - Ecuador 17
JP - Giappone 17
PK - Pakistan 16
CO - Colombia 15
ES - Italia 15
MA - Marocco 15
ID - Indonesia 13
UZ - Uzbekistan 11
CI - Costa d'Avorio 10
GR - Grecia 10
VE - Venezuela 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
KR - Corea 8
LT - Lituania 8
PE - Perù 8
CL - Cile 7
KE - Kenya 7
SA - Arabia Saudita 7
TW - Taiwan 7
AU - Australia 6
IL - Israele 6
IR - Iran 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
GT - Guatemala 5
JO - Giordania 5
MY - Malesia 5
OM - Oman 5
SV - El Salvador 5
TH - Thailandia 5
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
CY - Cipro 4
EE - Estonia 4
HN - Honduras 4
JM - Giamaica 4
PA - Panama 4
TN - Tunisia 4
BH - Bahrain 3
CG - Congo 3
DK - Danimarca 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
GP - Guadalupe 2
HR - Croazia 2
PR - Porto Rico 2
PT - Portogallo 2
AM - Armenia 1
BS - Bahamas 1
GY - Guiana 1
HT - Haiti 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
Totale 9.316
Salva come PNG Salva come JPEG
Città #
Singapore 555
Ashburn 541
Chandler 357
San Jose 334
Dublin 319
Santa Clara 266
Hong Kong 189
Beijing 162
Dallas 161
Ho Chi Minh City 150
Council Bluffs 121
Hanoi 114
Los Angeles 114
Jacksonville 110
New York 109
Johannesburg 106
Dearborn 105
Boardman 102
Parma 102
Ann Arbor 92
Shanghai 81
Nanjing 73
Lauterbourg 55
Princeton 48
Vienna 48
Izmir 44
Munich 40
Hefei 38
Jinan 37
Helsinki 34
São Paulo 34
Toronto 30
Turku 30
Wilmington 30
Shenyang 28
San Mateo 27
Tianjin 25
Buffalo 24
Chicago 24
Bologna 23
Da Nang 23
Montreal 22
Seattle 22
Moscow 21
Rome 20
Columbus 19
Nanchang 19
Bremen 18
Brussels 18
Milan 18
Changsha 17
Hebei 17
Woodbridge 17
London 16
Marseille 16
North Bergen 16
Tokyo 16
Warsaw 16
Atlanta 15
Guangzhou 14
Kunming 14
Phoenix 14
Pune 14
Frankfurt am Main 13
Haiphong 13
Rio de Janeiro 13
Ankara 12
Baghdad 12
Denver 12
Des Moines 12
Modena 12
Nuremberg 12
San Francisco 12
Hangzhou 11
Abidjan 10
Brooklyn 10
The Dalles 10
Athens 9
Biên Hòa 9
Manchester 9
Naples 9
Poplar 9
Redondo Beach 9
Stockholm 9
Tashkent 9
Haikou 8
Houston 8
Reggio Emilia 8
Rio Saliceto 8
Taiyuan 8
Zhengzhou 8
Amsterdam 7
Charlotte 7
Chennai 7
Fidenza 7
Hải Dương 7
Jakarta 7
Nairobi 7
Ningbo 7
Orem 7
Totale 5.631
Salva come PNG Salva come JPEG
Nome #
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 220
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 219
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 211
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 209
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 203
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 201
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 192
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 189
Microsatellite instability in colorectal cancer 188
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 188
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 184
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 183
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 183
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 180
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 179
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 179
Notch expression and bevacizumab efficacy in colorectal cancer patients 178
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 175
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 173
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 172
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 168
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 168
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 168
Classification of gastric endocrine cells at the light and electron microscopical levels 167
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. 165
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 164
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 163
Atrophic body gastriris patients with enterochromaffin-like cell dysplasia are at increased risk for development of type I gastric carcinoid 160
Different patterns of 11q allelic losses in digestive endocrine tumors 160
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 158
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 157
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 157
Pancreatic Polypeptide-related tumors 156
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 155
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 155
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study 155
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 153
Pleomorph poorly differentiated endocrine carcinoma of the rectum 152
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis 147
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy 141
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 140
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 139
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 135
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 135
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 132
Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features 131
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapy 127
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient 122
P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas 122
Surgical treatment of multiple sporadic colorectal carcinoma 120
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 118
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 113
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 109
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 109
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients 105
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature 103
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 100
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 98
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 85
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 84
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 66
The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications 34
Totale 9.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022268 0 0 0 18 13 8 42 24 16 17 34 96
2022/20231.232 106 155 66 96 101 146 12 85 393 14 43 15
2023/2024435 27 29 9 7 30 121 42 41 17 24 25 63
2024/20251.433 36 65 97 104 175 182 74 50 162 108 119 261
2025/20263.885 335 248 414 460 565 246 348 140 533 261 206 129
2026/2027729 105 155 173 296 0 0 0 0 0 0 0 0
Totale 9.402